Maxigen Biotech (Taiwan) Today
Maxigen Biotech is selling for under 50.30 as of the 31st of January 2025; that is 3.27 percent decrease since the beginning of the trading day. The stock's lowest day price was 50.2. The performance scores are derived for the period starting the 1st of January 2025 and ending today, the 31st of January 2025. Click here to learn more.
Valuation
Check how we calculate scores
Maxigen Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Maxigen Biotech's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Maxigen Biotech or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Thematic Idea | IT (View all Themes) |
| Business Concentration | IT, Drug Manufacturers - Major, Healthcare, Computing (View all Sectors) |
Maxigen Biotech (1783) is traded on Taiwan Stock Exchange in Taiwan and employs 20 people. The company currently falls under 'Mid-Cap' category with a current market capitalization of 5.02 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Maxigen Biotech's market, we take the total number of its shares issued and multiply it by Maxigen Biotech's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Maxigen Biotech operates under Healthcare sector and is part of Drug Manufacturers - Major industry. The entity has 84.7 M outstanding shares.
Maxigen Biotech has accumulated about 390.34 M in cash with 117.59 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 5.62.
Check Maxigen Biotech Probability Of Bankruptcy
Maxigen Biotech Risk Profiles
Although Maxigen Biotech's alpha and beta are two of the key measurements used to evaluate Maxigen Biotech's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 1.17 | |||
| Semi Deviation | 1.29 | |||
| Standard Deviation | 1.65 | |||
| Variance | 2.73 |
Maxigen Stock Against Markets
Maxigen Biotech Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Maxigen Biotech stock to make a market-neutral strategy. Peer analysis of Maxigen Biotech could also be used in its relative valuation, which is a method of valuing Maxigen Biotech by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Maxigen Biotech Corporate Management
Elected by the shareholders, the Maxigen Biotech's board of directors comprises two types of representatives: Maxigen Biotech inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Maxigen. The board's role is to monitor Maxigen Biotech's management team and ensure that shareholders' interests are well served. Maxigen Biotech's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Maxigen Biotech's outside directors are responsible for providing unbiased perspectives on the board's policies.
| PoHung Lai | Deputy Mang | Profile | |
| ChingTing Chen | GM Director | Profile | |
| WanHow You | Financial Officer | Profile | |
| Karen Lee | Sr Admin | Profile |
Additional Tools for Maxigen Stock Analysis
When running Maxigen Biotech's price analysis, check to measure Maxigen Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Maxigen Biotech is operating at the current time. Most of Maxigen Biotech's value examination focuses on studying past and present price action to predict the probability of Maxigen Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Maxigen Biotech's price. Additionally, you may evaluate how the addition of Maxigen Biotech to your portfolios can decrease your overall portfolio volatility.